Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin–Johnson syndrome
✍ Scribed by Hiroyuki Tsujii*; Jörg König*; Daniel Rost*; Birgit Stöckel*; Ulrich Leuschner‡; Dietrich Keppler*
- Book ID
- 118522052
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 450 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Treatment of hepatocellular carcinoma (HCC) by chemotherapy is often impeded by the intrinsic multidrug resistance (MDR) of this frequent primary cancer of the liver. The MDR phenotype can be caused by ATP-dependent export of chemotherapeutic drugs across the plasma membrane being mediated by transp
The human multidrug resistance protein 2 (MRP2), also termed as the canalicular multispecific organic anion transporter (cMOAT), is a member of the adenosine triphosphatebinding cassette transporter superfamily. In the liver, MRP2 mediates the multispecific efflux of various types of organic anions,